Intravenous fluid monitoring devices market seen reaching $8.5 billion by 2030

The intravenous fluid monitoring devices market is projected to grow from $5.59 billion in 2025 to $8.5 billion by 2030, driven by rising hospitalizations, chronic disease cases and demand for remote care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The market sits at the intersection of patient safety, hospital efficiency and remote care. - Growth in home healthcare and remote monitoring is expanding where and how intravenous fluid monitoring devices are used. - The forecast points to stronger demand for devices that improve fluid accuracy, reduce manual oversight and support chronic care.

What happened: - The intravenous fluid monitoring devices market was valued at $5.59 billion in 2025. - The market is expected to reach $6.1 billion in 2026. - The report projects the market will climb to $8.5 billion by 2030. - The forecast implies an 8.7% CAGR through 2030. - The Business Research Company released its Global Market Report 2026 covering market size, trends and forecasts for 2026-2035. - A free sample of the report is available here.

The details: - Rising hospitalization rates, more frequent use of intravenous therapies and dependence on manual IV monitoring are key near-term growth drivers. - Growth in chronic illnesses and hospital infrastructure also supported market expansion. - Wireless and smart intravenous devices are among the main innovation areas. - Remote patient monitoring, home healthcare services and value-based healthcare are expected to support future demand. - AI-powered clinical decision support systems are also expected to be integrated more often. - The report highlights increased use of wireless IV fluid monitoring, more precise flow and volume measurements, expanded use in home care, stronger patient safety measures and multi-parameter monitoring systems as key trends. - Intravenous fluid monitoring devices track and control fluid delivery directly into a patient’s bloodstream through an IV line. - The devices help ensure the correct fluid type and volume are delivered safely while monitoring physiological responses to treatment. - The report says these devices are vital across multiple clinical settings. - The full report is available here.

Between the lines: - The home healthcare shift is a major demand signal because IV monitoring is moving beyond hospitals into more decentralized care settings. - The report cites an aging population, medical technology advances, higher chronic disease prevalence and patient preference for at-home care as drivers of home healthcare growth. - The cited home healthcare economics underscore why providers want better monitoring tools: Unbiased reported average costs of about $30 per hour and roughly $18,144 per month. - Unbiased also projected home healthcare spending growth of 5.4% to 8.5% in 2024, pointing to sustained demand pressure. - North America held the largest market share in 2025, which suggests the region remains the early commercial center for adoption. - Asia-Pacific is expected to grow fastest, signaling a shift in future volume toward emerging and expanding healthcare markets.

What's next: - The report expects wireless, smart and AI-enabled monitoring tools to shape the next phase of the market. - Home care adoption is likely to remain a key growth path as more treatment moves outside hospitals. - The Business Research Company has added market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspot infographics to its 2026 reports. - The company also says the updated reports include key technologies and future trend analysis, plus refreshed graphics and tables. - Contact details and social links were included in the release for further inquiries and follow-up.